Makers of diabetes drug will pay $90 million

In 2007, Dr. Stephen Nissan, a cardiologist at the Cleveland Clinic, published an article in the New England Journal of Medicine that found a 43% increased chance of heart attack for patients taking a diabetes drug called Avandia. Nissan was one among many critics of the drug, which has since been pulled from the market. GlaxoSmithKline, the manufacturers of the drug, will pay a $90 million settlement fee, to be divided amongst 37 states and the District of Columbia, under allegations that they knew of the risks for four years, but fought to keep them from the public.